Purchases and Sales Made in Q4 2023 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q4 2023. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 08, 2024
Q4 2023
|
Cowen And Company, LLC
|
BUY
|
- |
256KNew |
$236K - $433K
|
256K
$456K
|
|
|
May 16, 2024
Q4 2023
|
Connective Capital Management, LLC
Palo Alto, CA |
BUY
|
- |
60KNew |
$55.2K - $101K
|
60K
$107K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
29.6KNew |
$27.2K - $50K
|
29.6K
$52.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
12.9K+ 38.74% |
$11.9K - $21.8K
|
46.2K
$82.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
6.18K+ 13.03% |
$5.68K - $10.4K
|
53.6K
$95.4K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
4.53KNew |
$4.17K - $7.66K
|
4.53K
$8.07K
|
|
|
Feb 14, 2024
Q4 2023
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
1.63KNew |
$1.5K - $2.75K
|
1.63K
$2.89K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.02KNew |
$937 - $1.72K
|
1.02K
$1.81K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.02KNew |
$937 - $1.72K
|
1.02K
$1.81K
|
|
|
Jan 24, 2024
Q4 2023
|
Allworth Financial LP
|
BUY
|
- |
89New |
$81.9 - $150
|
89
$158
|
|
|
Jan 10, 2024
Q4 2023
|
Sound Income Strategies, LLC
|
BUY
|
- |
22New |
$20.2 - $37.2
|
22
$39.2
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-24- 2.21% |
$22.1 - $40.6
|
1.06K
$1.89K
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-200- 30.77% |
$184 - $338
|
450
$801
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.52K- 30.26% |
$2.32K - $4.26K
|
5.81K
$10.3K
|
|
|
Feb 14, 2024
Q4 2023
|
Invenomic Capital Management LP
Boston, MA |
SELL
|
- |
-32.4K- 4.23% |
$29.8K - $54.7K
|
732K
$1.3M
|